Literature DB >> 24130323

Recent data do not provide evidence that resveratrol causes 'mainly negative' or 'adverse' effects on exercise training in humans.

James M Smoliga1, Otis L Blanchard.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2013        PMID： 24130323      PMCID： PMC3810822          DOI： 10.1113/jphysiol.2013.262956

Source DB:  PubMed          Journal:  J Physiol        ISSN： 0022-3751            Impact factor:   5.182


× No keyword cloud information.
  10 in total

1.  Controlled endurance exercise training and VO2max changes in older adults: a meta-analysis.

Authors:  Guoyuan Huang; Cheryl A Gibson; Zung V Tran; Wayne H Osness
Journal:  Prev Cardiol       Date:  2005

2.  Erroneous analyses of interactions in neuroscience: a problem of significance.

Authors:  Sander Nieuwenhuis; Birte U Forstmann; Eric-Jan Wagenmakers
Journal:  Nat Neurosci       Date:  2011-08-26       Impact factor: 24.884

3.  ESC Guidelines on the diagnosis and treatment of peripheral artery diseases: Document covering atherosclerotic disease of extracranial carotid and vertebral, mesenteric, renal, upper and lower extremity arteries: the Task Force on the Diagnosis and Treatment of Peripheral Artery Diseases of the European Society of Cardiology (ESC).

Authors:  Michal Tendera; Victor Aboyans; Marie-Louise Bartelink; Iris Baumgartner; Denis Clément; Jean-Philippe Collet; Alberto Cremonesi; Marco De Carlo; Raimund Erbel; F Gerry R Fowkes; Magda Heras; Serge Kownator; Erich Minar; Jan Ostergren; Don Poldermans; Vincent Riambau; Marco Roffi; Joachim Röther; Horst Sievert; Marc van Sambeek; Thomas Zeller
Journal:  Eur Heart J       Date:  2011-08-26       Impact factor: 29.983

4.  Type I: families, planning and errors.

Authors:  Gordon B Drummond; Sarah L Vowler
Journal:  J Physiol       Date:  2012-10-15       Impact factor: 5.182

5.  C-reactive protein, interleukin-6, and soluble adhesion molecules as predictors of progressive peripheral atherosclerosis in the general population: Edinburgh Artery Study.

Authors:  Ioanna Tzoulaki; Gordon D Murray; Amanda J Lee; Ann Rumley; Gordon D O Lowe; F Gerald R Fowkes
Journal:  Circulation       Date:  2005-08-08       Impact factor: 29.690

6.  Acute exposure to resveratrol inhibits AMPK activity in human skeletal muscle cells.

Authors:  P Skrobuk; S von Kraemer; M M Semenova; A Zitting; H A Koistinen
Journal:  Diabetologia       Date:  2012-08-17       Impact factor: 10.122

7.  Repeat dose study of the cancer chemopreventive agent resveratrol in healthy volunteers: safety, pharmacokinetics, and effect on the insulin-like growth factor axis.

Authors:  Victoria A Brown; Ketan R Patel; Maria Viskaduraki; James A Crowell; Marjorie Perloff; Tristan D Booth; Grygoriy Vasilinin; Ananda Sen; Anna Maria Schinas; Gianfranca Piccirilli; Karen Brown; William P Steward; Andreas J Gescher; Dean E Brenner
Journal:  Cancer Res       Date:  2010-10-08       Impact factor: 12.701

8.  Resveratrol blunts the positive effects of exercise training on cardiovascular health in aged men.

Authors:  Lasse Gliemann; Jakob Friis Schmidt; Jesper Olesen; Rasmus Sjørup Biensø; Sebastian Louis Peronard; Simon Udsen Grandjean; Stefan Peter Mortensen; Michael Nyberg; Jens Bangsbo; Henriette Pilegaard; Ylva Hellsten
Journal:  J Physiol       Date:  2013-07-22       Impact factor: 5.182

9.  Resveratrol supplementation does not improve metabolic function in nonobese women with normal glucose tolerance.

Authors:  Jun Yoshino; Caterina Conte; Luigi Fontana; Bettina Mittendorfer; Shin-ichiro Imai; Kenneth B Schechtman; Charles Gu; Iris Kunz; Filippo Rossi Fanelli; Bruce W Patterson; Samuel Klein
Journal:  Cell Metab       Date:  2012-10-25       Impact factor: 27.287

10.  A healthier approach to clinical trials evaluating resveratrol for primary prevention of age‐related diseases in healthy populations.

Authors:  James M Smoliga; E Sage Colombo; Matthew J Campen
Journal:  Aging (Albany NY)       Date:  2013-07       Impact factor: 5.682
  10 in total
  6 in total

1.  Reply fromLasse Gliemann, Jesper Olesen, Rasmus Sjorup Bienso, Stefan Peter Mortensen, Michael Nyberg, Jens Bangsbo, Henriette Pilegaard and Ylva Hellsten.

Authors:  Lasse Gliemann; Jesper Olesen; Rasmus Sjørup Biensø; Stefan Peter Mortensen; Michael Nyberg; Jakob F Schmidt; Jens Bangsbo; Henriette Pilegaard; Ylva Hellsten
Journal:  J Physiol       Date:  2014-02-01       Impact factor: 5.182

2.  Resveratrol as a supplement to exercise training: friend or foe?

Authors:  Thomas W Buford; Stephen D Anton
Journal:  J Physiol       Date:  2014-02-01       Impact factor: 5.182

Review 3.  Resveratrol supplementation: Where are we now and where should we go?

Authors:  Marta G Novelle; Devin Wahl; Carlos Diéguez; Michel Bernier; Rafael de Cabo
Journal:  Ageing Res Rev       Date:  2015-01-24       Impact factor: 10.895

Review 4.  Dietary Antioxidants as Modifiers of Physiologic Adaptations to Exercise.

Authors:  Robert T Mankowski; Stephen D Anton; Thomas W Buford; Christiaan Leeuwenburgh
Journal:  Med Sci Sports Exerc       Date:  2015-09       Impact factor: 5.411

Review 5.  Significance of Resveratrol in Clinical Management of Chronic Diseases.

Authors:  Awais Wahab; Kuo Gao; Caixia Jia; Feilong Zhang; Guihua Tian; Ghulam Murtaza; Jianxin Chen
Journal:  Molecules       Date:  2017-08-18       Impact factor: 4.411

Review 6.  Quercetin, Epigallocatechin Gallate, Curcumin, and Resveratrol: From Dietary Sources to Human MicroRNA Modulation.

Authors:  Erika Cione; Chiara La Torre; Roberto Cannataro; Maria Cristina Caroleo; Pierluigi Plastina; Luca Gallelli
Journal:  Molecules       Date:  2019-12-23       Impact factor: 4.411
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.